FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091726 [Registered on: 25/07/2025] Trial Registered Prospectively
Last Modified On: 21/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Improving Jaundice Care for Newborns in India: Using a Quick Skin Test Instead of Blood Draws  
Scientific Title of Study   The Usefulness of Transcutaneous Bilirubinometry in Newborns: Implications on Clinical Practice in Indian Population. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
IEC/2024/DNB/PEAD/45  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  POORVI BISHT 
Designation  Principal Investigator 
Affiliation  H. N. Reliance Foundation Hospital and Research Centre 
Address  Department of Pediatrics,Heritage Building, 1st Floor, Raja Ram Mohan Roy Road,Prathna Samaj, Girgaon

Mumbai
MAHARASHTRA
400004
India 
Phone  8511355646  
Fax    
Email  Poorvi.Bisht@rfhospital.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rahul J Verma 
Designation  Director of Pediatric Sciences 
Affiliation  Sir H. N. Reliance Foundation Hospital and Research Centre 
Address  Department of Pediatrics,Heritage Building, 1st Floor, Raja Ram Mohan Roy Road,Prathna Samaj, Girgaon

Mumbai
MAHARASHTRA
400004
India 
Phone  9930909956  
Fax    
Email  Rahul.J.Verma@rfhospital.org  
 
Details of Contact Person
Public Query
 
Name  POORVI BISHT 
Designation  Principal Investigator 
Affiliation  Sir H. N. Reliance Foundation Hospital and Research Centre 
Address  Department of Pediatrics,Heritage Building, 1st Floor, Raja Ram Mohan Roy Road,Prathna Samaj, Girgaon

Mumbai
MAHARASHTRA
400004
India 
Phone  8511355646  
Fax    
Email  Poorvi.Bisht@rfhospital.org  
 
Source of Monetary or Material Support  
Sir H. N. Reliance Foundation Hospital and Research Centre 
 
Primary Sponsor  
Name  Dr Poorvi Bisht 
Address  Sir H. N. Reliance Foundation Hospital and Research Centre, Department of Pediatrics,Heritage Building, 1st Floor, Raja Ram Mohan Roy Road,Prathna Samaj, Girgaon, Mumbai, Maharashtra 400004 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Poorvi Bisht  Sir H. N. Reliance Foundation Hospital and Research Centre  Department of Pediatrics,Heritage Building, 1st Floor, Raja Ram Mohan Roy Road,Prathna Samaj, Girgaon, Mumbai, Maharashtra 400004
Mumbai
MAHARASHTRA 
8511355646

Poorvi.Bisht@rfhospital.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Neonates till day 10 of life who will develope physiological jaundice. 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  10.00 Day(s)
Gender  Both 
Details  All newborns (less than 10 days of life) irrespective of the age of gestation, parity, mode of delivery, mode of feeding who have jaundice that seem significant to the naked eye. (Krammer zone 3 and beyond)
Newborns with jaundice who have not received any treatment in the form of exchange blood transfusion.
Newborns receiving phototherapy with a photo opaque heat reflective patch over the area of the forehead, and sternum where TCB measurement will be taken from.
 
 
ExclusionCriteria 
Details  Neonates whose age is more than 10 days of life.
Neonates who needed exchange transfusion.
When a serum value is not available.
Severe multiple anomalies.
Patients with known liver disease, conjugated hyperbilirubinemia, or metabolic disorders that affect bilirubin metabolism.
Those who had culture-proven sepsis.
Unwillingness to participate or refusal of consent.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The findings of this study will have implications for clinical practice in managing neonatal jaundice. If TcB measurements are found to be accurate and reliable, they could replace serum bilirubin measurements in some settings, reducing the need for invasive procedures and improving the care of newborns with jaundice
 
at baseline, 18 months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="97"
Sample Size from India="97" 
Final Enrollment numbers achieved (Total)= "97"
Final Enrollment numbers achieved (India)="97" 
Phase of Trial   N/A 
Date of First Enrollment (India)   09/08/2025 
Date of Study Completion (India) 15/12/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Aim:

To determine the correlation between transcutaneous bilirubin (TcB) levels and total serum bilirubin levels in newborns, born in a tertiary care hospital.


Objective:

  1. To determine the accuracy of TcB measurements with respect to corresponding serum bilirubin levels. 

  2. To evaluate the effectiveness of TcB measurements in predicting the need for phototherapy.

 
Close